Roflumilast enhances cisplatin ‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via cAMP/PKA/CREB‐FtMt signalling axis

Cell Proliferation, EarlyView.

Source: Cell Proliferation - August 2, 2018 Category: Cytology Authors: Shipeng Gong , Yongning Chen , Fanliang Meng , Yadi Zhang , Chanyuan Li , Guangping Zhang , Wu Huan , Fei Wu Source Type: research